首页>
外国专利>
APOMORPHINE INHIBITORS OF AMYLOID-Beta (ABeta) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE
APOMORPHINE INHIBITORS OF AMYLOID-Beta (ABeta) FIBRIL FORMATION AND THEIR USE IN AMYLOIDOSIS BASED DISEASE
展开▼
机译:淀粉样β-淀粉样蛋白(ABeta)原纤维形成的吗啡抑制剂及其在基于淀粉样变性的疾病中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
Described is a new class of small molecule inhibitors of amyloid β protein (Aβ) aggregation, based on apomorphine. These molecules target the nucleation phase of Aβ self-assembly and interfere effectively with aggregation of Aβ 1-40 into amyloid fibrils invitro as determined by transmission electron microscopy, Thioflavin T (ThT) fluorescence, and velocity sedimentation. Structure-activity studies using apomorphine analogues demonstrate that 10, 11-dihydroxy substitutions of the D ring are preferred for the inhibitory effectiveness of these aporphines, and that methylation of these hydroxyl groups reduces their inhibitory potency. The ability of these small molecules to inhibit Aβ amyloid fibril formation appears to be linked to their ability to undergo auto-oxidation in solution, implicating an auto-oxidation product as the active A&beta, inhibitor. Sedimentation velocity and electron microscopy studies demonstrate that apomorphine and analogues facilitate oligomerization of Aβ into short nonfibrillar soluble assemblies, but inhibit Aβ fibrilization.
展开▼